Koulaouzidis A, Iakovidis DK, Karargyris A, Rondonotti E. Wireless endoscopy in 2020: Will it still be a capsule? World J Gastroenterol 2015; 21(17): 5119-5130 [PMID: 25954085 DOI: 10.3748/wjg.v21.i17.5119]
Corresponding Author of This Article
Anastasios Koulaouzidis, MD, FRPCE, FEBG, FACG, The Royal Infirmary of Edinburgh, Endoscopy Unit, 51 Little France Crescent, EH16 4SA Edinburgh, Scotland, United Kingdom. akoulaouzidis@hotmail.com
Research Domain of This Article
Gastroenterology & Hepatology
Article-Type of This Article
Editorial
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Author contributions: All authors contributed to this manuscript.
Conflict-of-interest: Koulaouzidis A has received research support from Given Imaging and SynMed UK, lecture honoraria from Dr Falk Pharma UK, and travel support from Abbott, Dr Falk Pharma UK, Almirall, and MSD. The rest of the authors declare no competing interests.
Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Correspondence to: Anastasios Koulaouzidis, MD, FRPCE, FEBG, FACG, The Royal Infirmary of Edinburgh, Endoscopy Unit, 51 Little France Crescent, EH16 4SA Edinburgh, Scotland, United Kingdom. akoulaouzidis@hotmail.com
Telephone: +44-131-2421126 Fax: +44-131-2421618
Received: December 24, 2014 Peer-review started: December 31, 2014 First decision: January 8, 2015 Revised: January 26, 2015 Accepted: March 18, 2015 Article in press: March 19, 2015 Published online: May 7, 2015 Processing time: 140 Days and 4.7 Hours
Abstract
Currently, the major problem of all existing commercial capsule devices is the lack of control of movement. In the future, with an interface application, the clinician will be able to stop and direct the device into points of interest for detailed inspection/diagnosis, and therapy delivery. This editorial presents current commercially-available new designs, European projects and delivery capsule and gives an overview of the progress required and progress that will be achieved -according to the opinion of the authors- in the next 5 year leading to 2020.
Core tip: Currently, the major problem of all existing commercial capsule devices is the lack of control of movement. In the future, with an interface application, the clinician will be able to stop and direct the device into points of interest for detailed inspection/diagnosis, and therapy delivery. This editorial presents current commercially-available new designs, European projects and delivery capsule and gives an overview of the progress required and progress that will be achieved - according to the opinion of the authors- in the next 5 year leading to 2020.
